North of Boston firm FreshPath Consulting, Inc. has continued a steady growth pattern by signing a number of deals with the local Biotech giant Genzyme Corporation. The largest deal involves managing a major LIMS upgrade project for their Clinical Labs in Framingham.
This project will enable the Clinical Specialty Lab to accomodate a large upcoming study by leveraging more of BLAZE LIMS features to automate processes that are currently managed manually .
Andrew Furst, Principal Consultant and Founder of FreshPath Consulting is thrilled with the continued growth pattern his firm is experiencing.
FreshPath Consulting has worked with a number of the area’s leading Biotech firms and continues to establish strategic partnerships with regional providers and product vendors to deliver quality services to the Pharma industry.
